New Jersey Headlines

Technological Advancements for Drug Development to Boost the HAE Pipeline Growth

Technological Advancements for Drug Development to Boost the HAE Pipeline Growth

Hereditary Angioedema (HAE) Therapeutics Pipeline Analysis
HAE currently exhibits a proliferating pipeline with 20 drug candidates, P&S Market Research

The study analyzed that HAE therapeutics pipeline comprises 20 drug candidates in different stages of development. HAE is a disease characterized by repeated incidents of swelling (angioedema). Some of the common body areas that get affected due to this disease include intestinal tract, face, limbs, and airway. The stress can cause a heart attack, but most often in the patients suffering from HAE, the swelling occurs with an unknown trigger.

Access Report Summary with Detailed TOC on “Hereditary Angioedema (HAE) Therapeutics Pipeline Analysis” at: https://www.psmarketresearch.com/market-analysis/hereditary-angioedema-therapeutics-pipeline-analysis

According to the research findings, most of the drug candidates of the HAE are being derived from the natural sources. The natural sources consist of various molecules such as gene therapies, biologicals, and RNA.

Download Sample Copy: https://www.psmarketresearch.com/market-analysis/hereditary-angioedema-therapeutics-pipeline-analysis/report-sample

Most of the companies have developed novel technologies for the development of drug candidates for the treatment of HAE. For instance, Arrowhead Pharmaceuticals, Inc. has established a drug discovery, and development platform that has broad licenses to fundamental intellectual property and extensive scientific expertise after more than a decade working on RNAi-based therapies. These technologically advanced platforms enable the players in the pipeline to develop effective new therapies rapidly, that are cost effective and potentially have lower risk, relative to traditional approaches. These technological advancements act as a key driver for pipeline growth.

Pre-Purchase Enquiry: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hereditary-angioedema-therapeutics-pipeline-analysis

The positive clinical results of HAE drug candidates are driving the pipeline growth. For instance, Attune Pharmaceuticals, Inc., announced the Pre-Clinical data results for ATN-249, a novel orally administered plasma kallikrein inhibitor for the treatment of HAE. Studies demonstrated that ATN-249 was highly selective and potent at plasma kallikrein inhibition in both biochemical inhibition and contact activation assays. Therefore, the positive clinical results of the compounds under the development for the treatment of HAE, are fueling the research and development investment being made by the players developing drugs for the treatment of HAE.

Some of the key players developing drugs for the treatment of HAE therapeutics include Shire plc, BioCryst Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc.

HAE Therapeutics Pipeline Analysis

  • By Phase
  • By Molecule Type
  • By Route of Administration
  • By Company

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication.  Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Media Contact
Company Name: P&S Market Research
Contact Person: Kundan
Email: Send Email
Phone: +1-888-778-7886
Address:347 5th Ave. #1402- 210
City: New York City
State: New York
Country: United States
Website: https://www.psmarketresearch.com/industry-report/pharmaceuticals

Calendar

January 2018
M T W T F S S
« Dec    
1234567
891011121314
15161718192021
22232425262728
293031